250 related articles for article (PubMed ID: 9656214)
21. [The etiological structure and epidemiological characteristics of viral hepatitis among servicemen].
Ogarkov PI; Malyshev VV
Voen Med Zh; 1992 Jun; (6):57-60. PubMed ID: 1326824
[TBL] [Abstract][Full Text] [Related]
22. [Prevalence of serum markers of hepatitis A and B viruses in Andalusian homosexual men].
Leal M; Ollero M; García de Pesquera F; Lissen E
Med Clin (Barc); 1985 May; 84(18):757-8. PubMed ID: 4021599
[No Abstract] [Full Text] [Related]
23. Prevalence of antibodies against hepatitis A virus, hepatitis B virus, and Treponema pallidum in Mauritius.
Schwarz TF; Kam CC; Min GL; Jilg W; Wilske B; Gürtler L; Deinhardt F
Scand J Infect Dis; 1991; 23(5):535-41. PubMed ID: 1662829
[TBL] [Abstract][Full Text] [Related]
24. [Prevalence of antibodies to hepatitis A, hepatitis B and hepatitis C viruses in the German population].
Thierfelder W; Meisel H; Schreier E; Dortschy R
Gesundheitswesen; 1999 Dec; 61 Spec No():S110-4. PubMed ID: 10726407
[TBL] [Abstract][Full Text] [Related]
25. [Viral markers of acute hepatitis: a study in 291 children and adults in Chile].
Velasco M; Puelma E; Katz R; Zacarías J
Rev Med Chil; 1982 Jun; 110(6):542-6. PubMed ID: 6819623
[No Abstract] [Full Text] [Related]
26. [The immune status against hepatitis A virus in medical residents].
Benito Ruesca R; Gil-Tomás J; Doiz Unzué O; López Cerero L
Med Clin (Barc); 1997 Jul; 109(6):236-7. PubMed ID: 9289557
[No Abstract] [Full Text] [Related]
27. [Hepatitis A, B, and C in an occupational center for the mentally handicapped].
Arnedo A; Latorre MD; Pac MR; Safont L; Guillén F; Aguinaga I
Enferm Infecc Microbiol Clin; 1998 Oct; 16(8):370-3. PubMed ID: 9835153
[TBL] [Abstract][Full Text] [Related]
28. Urticaria and acute hepatitis A virus infection.
Scully LJ; Ryan AE
Am J Gastroenterol; 1993 Feb; 88(2):277-8. PubMed ID: 8380951
[TBL] [Abstract][Full Text] [Related]
29. [Detection and frequency of inapparent infections in epidemic foci of hepatitis A].
Benda R; König J; Mankovecký L; Hejná M; Sulcová M; Slezácek J; Kmet P; Machula F; Radovnický V
Cas Lek Cesk; 1986 Dec; 125(52):1598-603. PubMed ID: 3026631
[No Abstract] [Full Text] [Related]
30. Prevalence of antibodies to hepatitis viruses in blood donors with a clinical history of hepatitis.
Vranckx R; Muylle L
Zentralbl Bakteriol; 1992 Apr; 276(4):540-7. PubMed ID: 1319249
[TBL] [Abstract][Full Text] [Related]
31. Infection of hepatitis A virus in Japanese haemophiliacs.
Hayashi K; Fukuda Y; Nakano I; Katano Y; Nagano K; Yokozaki S; Hayakawa T; Toyoda H; Takamatsu J
J Infect; 2001 Jan; 42(1):57-60. PubMed ID: 11243755
[TBL] [Abstract][Full Text] [Related]
32. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
[TBL] [Abstract][Full Text] [Related]
33. Seroepidemiology of hepatitis B virus markers among hospital health care workers. Analysis of certain potential risk factors.
Daw MA; Siala IM; Warfalli MM; Muftah MI
Saudi Med J; 2000 Dec; 21(12):1157-60. PubMed ID: 11360090
[TBL] [Abstract][Full Text] [Related]
34. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].
Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073
[TBL] [Abstract][Full Text] [Related]
35. [Prevalence of antibodies against hepatitis A in school children].
Riedemann S; Ibarra H; Reinhardt G; Frösner G; Safary A
Rev Med Chil; 1998 Oct; 126(10):1161-4. PubMed ID: 10030086
[TBL] [Abstract][Full Text] [Related]
36. [The possibility of using an indirect method of fluorescent antibodies to the hepatitis A virus in epidemic control practice].
Perepelkin VS; Polianin VA; Zhukova TM; Nedospelov IuN; Ezhov VA
Voen Med Zh; 1989 Sep; (9):33-5. PubMed ID: 2556858
[No Abstract] [Full Text] [Related]
37. [Prevalence of infection by hepatitis viruses in a rural area. Analysis according to risk factors and alcohol consumption].
Nalpas B; Zylberberg H; Dubois F; Presles MA; Gillant JC; Lienard M; Delemotte B; Bréchot C
Gastroenterol Clin Biol; 2000 May; 24(5):536-40. PubMed ID: 10891742
[TBL] [Abstract][Full Text] [Related]
38. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination.
Salleras L; Domínguez A; Bruguera M; Plans P; Costa J; Cardeñosa N; Batalla J; Plasència A
Vaccine; 2007 Dec; 25(52):8726-31. PubMed ID: 18045753
[TBL] [Abstract][Full Text] [Related]
39. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver].
Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JD; Ruiz Estremera A
Med Clin (Barc); 1998 Sep; 111(9):341-6. PubMed ID: 9810537
[No Abstract] [Full Text] [Related]
40. [Current status of immunity to hepatitis A virus in various adult groups].
Ibarra H; Riedemann S; Prado V; Reinhardt G; Vega I; Potin M; Frick P
Rev Med Chil; 1999 Oct; 127(10):1165-8. PubMed ID: 10835731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
